Meeting on the Med 2025
Join Catalent at the Meeting on the Med 2025, a pivotal event in the biopharmaceutical sector that brings together leaders and innovators from around the world to discuss emerging trends and collaborative opportunities in Cell and Gene Therapy.
Date: April 15-17, 2025
Location: Rome, Italy
JOIN US!
As an sponsor, Catalent will showcase our pioneering technologies and comprehensive services designed to accelerate the journey to clinic and patients.
Meet our team to learn more about our capabilities and explore how we can support your product development and commercialization efforts.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Rupa Pike (Senior Director and Global Head of Strategic Alliances) will moderate a panel entitled: Expanding Access to CAR-T Therapies: Overcoming Barriers and Driving Adoption.
Wednesday, April 16 | 11:30am
Frederic Cedrone (Vice President Corporate Innovation) is giving a Catalent company presentation.
Tuesday, April 15 | 3:45pm
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
